Having more healthy practice was associated with low white blood cell counts in middle-aged Japanese male and female workers

White blood cell count and clustered components of metabolic syndrome: A study in western Iran

Background

White blood cell count (WBC) is one of the objective parameters of systemic inflammation. The aim of present study was to evaluate the relationship between WBC count and metabolic syndrome.

Methods

In this study on Lor population in Borujerd province (West of Iran), from 2011 to 2013, 800 persons were enrolled. MetS was defined based on ATP III criteria. Differences among the quartiles of WBC were examined by one-way analysis of variance.

Results

Only 14.7% did not have any of the five components and 43% of all subjects had metabolic syndrome. The means of WBC count in MetS group were significantly higher than the control group (p<0.0001). In subjects without any MetS components, the means of WBC was 5.321 /µL, and it was 5.664, 5.714, 5.961, 6.302, and 6.572 /µL in subjects with 1, 2, 3, 4, and 5 components, respectively. These differences show a significant increasing trend (p<0.0001).

Conclusion

WBC count was associated with clustered components of metabolic syndrome. It seems that WBC counts could be considered as a predictive factor for metabolic syndrome in preventive medicine.

Ethanol extract of mango seed is a suitable plant-based replacement for synthetic antioxidants in pig grower–finisher diets

The objective of the present study was to evaluate the inclusion of ethanol extracts of mango seed (EEMS) in growing–finishing pig diets on lipid stability and antioxidant potential of feed, animal performance, carcass traits as well as haematological and biochemical parameters in the serum. Thirty-two barrows that were 60 days old and weighed 20.20 ± 1.34 kg were used in a randomised-block design with four treatments and eight replicates. The treatments consisted of the following: diet without antioxidant addition (negative control); diet with 200 mg of butylate hydroxytoluene/kg (positive control); diet with 200 mg EEMS/kg (EEMS200); and diet with 400 mg EEMS/kg (EEMS400). Diet with synthetic (butylate hydroxytoluene) and natural antioxidants presented better oxidative stability and antioxidant potential than did the negative control. Animals fed 400 mg EEMS/kg presented greater weight gain up to 110 days (P &lt; 0.05). Pigs fed diet containing 200 mg EEMS/kg showed a decrease in red blood cells (P &lt; 0.001) and a higher average corpuscular volume (P &lt; 0.0001), whereas pigs fed control diet had lower average corpuscular haemoglobin concentration than did those in other treatments (P &lt; 0.01). At 140 days of age, dietary addition of 400 mg EEMS/kg decreased malondialdehyde and increased antioxidant potential (2,2-diphenyl-1-picryl hydrazyl method) in serum, with the highest phenolic compound concentration found in the serum of pigs fed diet with 200 mg EEMS/kg. The total antioxidant activity in the serum was not influenced by the treatments (P &gt; 0.05). Ethanol mango extracts can be used as an antioxidant in growing–finishing pig diets at levels of 200 and 400 mg/kg without impairment of performance, carcass traits, serum and biochemical parameters. The dietary addition of EEMS at 400 mg/kg improves the performance of pigs at growing phase and contributes to an increase in circulating phenolic compounds, improving the lipid stability and the antioxidant potential of the serum.

A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies

To monitor inflammation in a meaningful way, the markers used must be valid: they must reflect the inflammatory process under study and they must be predictive of future health status. In 2009, the Nutrition and Immunity Task Force of the International Life Sciences Institute, European Branch, organized an expert group to attempt to identify robust and predictive markers, or patterns or clusters of markers, which can be used to assess inflammation in human nutrition studies in the general population. Inflammation is a normal process and there are a number of cells and mediators involved. These markers are involved in, or are produced as a result of, the inflammatory process irrespective of its trigger and its location and are common to all inflammatory situations. Currently, there is no consensus as to which markers of inflammation best represent low-grade inflammation or differentiate between acute and chronic inflammation or between the various phases of inflammatory responses. There are a number of modifying factors that affect the concentration of an inflammatory marker at a given time, including age, diet and body fatness, among others. Measuring the concentration of inflammatory markers in the bloodstream under basal conditions is probably less informative compared with data related to the concentration change in response to a challenge. A number of inflammatory challenges have been described. However, many of these challenges are poorly standardised. Patterns and clusters may be important as robust biomarkers of inflammation. Therefore, it is likely that a combination of multiple inflammatory markers and integrated readouts based upon kinetic analysis following defined challenges will be the most informative biomarker of inflammation.

Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

Serotonin producing endocrine carcinoma of small intestine (ileal carcinoid) is a clinically distinct endocrine tumor. It is generally considered as a sporadic disease and its molecular etiology is poorly understood. We report comprehensive clinical and molecular studies of 55 sporadic and familial patients diagnosed with this condition. Nine pedigrees encompassing 23 affected subjects were established, consistent with autosomal dominant mode of inheritance. Familial and sporadic patients demonstrated indistinguishable clinical pictures. Molecular analyses of 61 tumors from 45 individuals, including eight familial and 37 sporadic patients, aimed at determination of global copy number aberrations using BAC and Illumina SNP arrays and gene expression profiling by Affymetrix chips. Chromosome 18 aberrations were identified in both sporadic and in familial tumors; 100% vs. 38%, respectively. Other, less frequent aberrations were also common for both groups. Global expression profiles revealed no differentially expressed genes. Frequent gain of chromosome 7 was exclusively observed in metastases, when patient matched primary tumors and metastases were compared. Notably, the latter aberration correlated with solid growth pattern morphology (P < 0.01), a histopathological feature that has previously been related to worse prognosis. The clinical and molecular similarities identified between sporadic and familial cases suggest a common pathogenetic mechanism involved in tumor initiation. The familial variant of ileal carcinoid represents a previously unrecognized autosomal dominant inherited tumor disease, which we propose to call Familial Ileal Endocrine Carcinoma (FIEC). Our findings indicate the location of a FIEC tumor suppressor gene near the telomere of 18q, involved in development of inherited and sporadic tumors.

Longitudinal study on white blood cell count and the incidence of metabolic syndrome

OBJECTIVE

Many studies have revealed that white blood cell count (WBC) is related to insulin resistance which is a central mechanism of metabolic syndrome (MetS). However, few cohort studies have examined the role of WBC in the development of MetS. We hypothesized that WBC is associated with the future development of MetS, and investigated the longitudinal incidence of MetS in healthy workers.

METHODS

WBC was measured in 5,073 workers (mean age 42.5 years) without MetS at baseline. The incidence of MetS was monitored over 7 years of follow-up, in relation to quartiles of WBC. During the follow-up, 925 participants were diagnosed as MetS.

RESULTS

Incidence of MetS was increased in participants with higher WBC: the rates of incidence of MetS were 22.6, 32.9, 42.9, and 57.5 per 1,000 person-years of follow-up in the 1st, 2nd, 3rd, and 4th quartiles of WBC, respectively. After adjustments for confounding factors, the adjusted hazards ratio (95% confidence interval) for MetS was 1.00 (reference), 1.22 (0.98 to 1.51), 1.52 (1.24 to 1.87), and 1.66 (1.35 to 2.04) through the quartiles of WBC, respectively, (p <0.001). This relationship was consistent among current smokers and never smokers, and among male and female genders, respectively.

CONCLUSION

WBC is useful in predicting the future development of MetS which leads to atherosclerotic diseases.